Pfizer falls as CFO Dave Denton prepares to step down
BUZZ-Pfizer falls as CFO Dave Denton prepares to step down ** Shares of Pfizer PFE.N fall 1.6% to $25.5 premarket
** Co says CFO Dave Denton will step down on August 15 to take a role in the consumer goods industry
** PFE names Cecile Guegan, senior vice president of finance for its global biopharmaceutical business, as interim CFO, effective August 16
** Denton, who joined Pfizer in 2022 from retail chain Lowe's LOW.N, oversaw major deals including the buyout of cancer drugmaker Seagen and obesity drug developer Metsera
** Up to last close, PFE shares up ~4% YTD
(Reporting by Mariam Sunny in Bengaluru)
Recent news on Pfizer
See all newsU.S. STOCKS ON THE MOVE-Chip stocks, Unicycive, Roblox
U.S. STOCKS ON THE MOVE-AMD, Roblox, Olin
Eli Lilly, Pfizer slip after US House panel probing China clinical trials
US House committee opens investigation into Merck, AbbVie China drug trials (updated)
Brief: U.S. House Committee Sends Letters To Pfizer, Eli Lilly & Bristol Myers Squibb Probing China Drug Trials